Concepts (57)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Intracranial Aneurysm | 2 | 2023 | 36 | 0.970 |
Why?
|
Embolization, Therapeutic | 2 | 2023 | 52 | 0.960 |
Why?
|
Pituitary Neoplasms | 1 | 2023 | 16 | 0.870 |
Why?
|
Aneurysm, Ruptured | 1 | 2023 | 15 | 0.830 |
Why?
|
Adenoma | 1 | 2023 | 56 | 0.820 |
Why?
|
Endovascular Procedures | 1 | 2023 | 33 | 0.810 |
Why?
|
Obesity, Morbid | 1 | 2023 | 87 | 0.760 |
Why?
|
Treatment Outcome | 4 | 2023 | 3231 | 0.290 |
Why?
|
Intracranial Hypertension | 1 | 2023 | 14 | 0.220 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2023 | 15 | 0.220 |
Why?
|
Endoscopy | 1 | 2023 | 168 | 0.190 |
Why?
|
Medical Futility | 1 | 2021 | 4 | 0.190 |
Why?
|
Leukoaraiosis | 1 | 2021 | 8 | 0.190 |
Why?
|
Multidetector Computed Tomography | 1 | 2021 | 11 | 0.190 |
Why?
|
Thrombectomy | 1 | 2021 | 30 | 0.180 |
Why?
|
Body Mass Index | 1 | 2023 | 419 | 0.180 |
Why?
|
Carotid Artery Diseases | 1 | 2020 | 15 | 0.180 |
Why?
|
Paraganglioma | 1 | 2020 | 4 | 0.170 |
Why?
|
Skull Base Neoplasms | 1 | 2020 | 15 | 0.170 |
Why?
|
Ultrasonography, Interventional | 1 | 2020 | 68 | 0.170 |
Why?
|
Printing, Three-Dimensional | 1 | 2018 | 9 | 0.160 |
Why?
|
Tomography, Optical Coherence | 1 | 2018 | 15 | 0.160 |
Why?
|
Models, Anatomic | 1 | 2018 | 43 | 0.160 |
Why?
|
Cerebrovascular Circulation | 1 | 2018 | 32 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 1 | 2023 | 1084 | 0.150 |
Why?
|
Humans | 7 | 2023 | 25692 | 0.150 |
Why?
|
Stents | 1 | 2018 | 80 | 0.150 |
Why?
|
Brain | 1 | 2021 | 1560 | 0.100 |
Why?
|
Cerebrospinal Fluid Leak | 1 | 2023 | 16 | 0.060 |
Why?
|
Encephalocele | 1 | 2023 | 20 | 0.050 |
Why?
|
Retrospective Studies | 2 | 2023 | 3220 | 0.050 |
Why?
|
Skull Base | 1 | 2023 | 25 | 0.050 |
Why?
|
Middle Aged | 3 | 2020 | 8403 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 198 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2023 | 532 | 0.050 |
Why?
|
Aged, 80 and over | 2 | 2021 | 4459 | 0.050 |
Why?
|
Clinical Decision-Making | 1 | 2021 | 37 | 0.050 |
Why?
|
Atrophy | 1 | 2021 | 88 | 0.050 |
Why?
|
Anatomic Landmarks | 1 | 2020 | 5 | 0.040 |
Why?
|
Automation | 1 | 2020 | 8 | 0.040 |
Why?
|
Angiography | 1 | 2020 | 29 | 0.040 |
Why?
|
Multimodal Imaging | 1 | 2020 | 25 | 0.040 |
Why?
|
Catheterization | 1 | 2020 | 39 | 0.040 |
Why?
|
Fluoroscopy | 1 | 2020 | 45 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 443 | 0.040 |
Why?
|
Male | 3 | 2021 | 13917 | 0.040 |
Why?
|
Disability Evaluation | 1 | 2021 | 252 | 0.040 |
Why?
|
Angiography, Digital Subtraction | 1 | 2018 | 10 | 0.040 |
Why?
|
Magnetic Resonance Angiography | 1 | 2018 | 28 | 0.040 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2018 | 48 | 0.040 |
Why?
|
Biocompatible Materials | 1 | 2018 | 88 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2020 | 646 | 0.040 |
Why?
|
Aged | 2 | 2021 | 8501 | 0.040 |
Why?
|
Prosthesis Design | 1 | 2018 | 447 | 0.030 |
Why?
|
Risk Factors | 1 | 2021 | 2224 | 0.030 |
Why?
|
Female | 2 | 2021 | 14273 | 0.030 |
Why?
|
Adult | 1 | 2020 | 7336 | 0.020 |
Why?
|